Om Analytical India Profile
Key Indicators
- Authorised Capital ₹ 50.00 K
- Paid Up Capital ₹ 50.00 K
- Company Age 9 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -99.74%
- Profit Growth -848.86%
- Ebitda -658.56%
- Net Worth -221.22%
- Total Assets 117.95%
About Om Analytical India
Om Analytical India Private Limited (OAIPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 December 2015 (Nine years and two months 9 days old ). Its registered office is in Satara, Maharashtra, India.
The Corporate was formerly known as Om Care Consultancy India Private Limited. The Company is engaged in the Travel And Hospitality Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 50.00 K and a paid-up capital of Rs 50.00 K , as per Ministry of Corporate Affairs (MCA) records.
Rajaram Patil and Sushma Patil serve as directors at the Company.
Company Details
-
Location
Satara, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85110PN2015PTC157402
-
Company No.
157402
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
02 Dec 2015
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Om Analytical India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajaram Patil
|
Director | 02-Dec-2015 | Current |
|
Sushma Patil
|
Director | 25-Mar-2022 | Current |
Financial Performance of Om Analytical India.
Om Analytical India Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 99.74% decrease. The company also saw a substantial fall in profitability, with a 848.86% decrease in profit. The company's net worth observed a substantial decline by a decrease of 221.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Om Analytical India?
In 2021, Om Analytical India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Omacon Analytical Solutions LlpRajaram Patil is a mutual person
-
Pharma Edge Centre (India) Private Limited
Rajaram Patil is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Om Analytical India?
Unlock and access historical data on people associated with Om Analytical India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Om Analytical India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Om Analytical India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
